// App-Quantinova.ai

: Longitudinal High-Throughput T Cell Repertoire Profiling of Chronic Lymphocytic Leukemia Patients Under Different Types of Treatment: Implications for Combination Strategies

Researchers

Presenter

  • Anna Vardi

Principal Investigators

  • Elisavet Vlachonikola

  • Nikolaos Ioannou

  • Fotis Psomopoulos

  • Konstantia Kotta

  • Despoina Papazoglou

  • Maria Kotouza

  • Evangelia Koravou

  • Chrysi Galigalidou

  • Katerina Gemenetzi

  • Kostas Pasentsis

  • Michalis Iskas

  • Niki Stavroyianni

  • Achilles Anagnostopoulos

  • Alan G. Ramsay

  • Kostas Stamatopoulos

  • Anastasia Hadzidimitriou

Medical Centers

  • Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece

  • School of Biology, Department of Genetics, Development and Molecular Biology,Aristotle University of Thessaloniki,Thessaloniki,Greece

  • Kings College London, London, United Kingdom

  • Center for Research and Technology Hellas-CERTH,Thessaloniki,Grecia

  • Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom

  • George Papanicolaou Hospital, Thessaloniki, Greece

Locations

  • Greece

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 25

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 38

  • Cluster of Differentiation 4

  • Cluster of differentiation 69

  • Cluster of differentiation 8A

  • T cell receptor beta locus

Drug/Treatment

  • Peptide vaccine

  • Idelalisib

  • Ibrutinib

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A